Skip to content

Cosmo Pharmaceuticals NV Sustainability Reports

The company is a specialized pharmaceutical and medical technology company focused on developing and manufacturing solutions for gastroenterology, dermatology, and AI-driven endoscopy. It works by licensing its clinical pipelines and approved drug platforms out to commercial partners globally.

Sector: Manufacturing

Country: Ireland

Exchange: SIX Swiss Exchange

ISIN: NL0011832936

15 reports from 2007 to 2024